Go back

EMA left waiting for ‘urgent’ Covid-19 resources

Image: Alessandro Zappalorto, via Shutterstock

EU has no plans to grant extra resources to struggling medicines agency before December

The European Medicines Agency is set to operate without the extra resources it says it urgently needs until at least December, when it expects the EU institutions that oversee its spending to have agreed its 2021 budget.

The EMA’s management board said at an October meeting that “it is critical that extra resources are urgently made available” so the agency can “fulfil its public health mandate and respond to patient needs in all disease areas”. It added that the EMA was “already diverting resources away from other important public health activities” due to Covid-19. 

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.